Genetic Disease

Lactobacillus Johnsonii Supplementation in Adults With T1D

Condition:   Type 1 Diabetes (T1D)
Interventions:   Drug: L. johnsonii Probiotic;   Drug: Placebo Capsule
Sponsors:   University of Florida;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Not yet recruiting
ClinicalTrials.gov: Genetic_Disease | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

May 24, 2019Comments OffAdults | Johnsonii | Lactobacillus | Supplementation
Prenatal Genetic Diagnosis by Genomic Sequencing

Condition:   Fetal Structural Anomalies
Intervention:   Diagnostic Test: Prenatal Genomic Sequencing
Sponsors:   Columbia University;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD);   Baylor College of Medicine;   University of North Carolina;   The George Washington University Biostatistics Center;   Oregon Health and Science University
Recruiting
ClinicalTrials.gov: Genetic_Disease | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

May 23, 2019Comments OffDiagnosis | Genetic | Genomic | Prenatal | Sequencing
PET Imaging of Neuroinflammation in Neurodegenerative Diseases Via a Novel TSPO Radioligand

Condition:   Dementia
Interventions:   Drug: 11C-ER176;   Drug: 11C-PIB
Sponsor:   National Institute of Mental Health (NIMH)
Not yet recruiting
ClinicalTrials.gov: Genetic_Disease | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

May 22, 2019Comments OffDiseases | Imaging | Neurodegenerative | Neuroinflammation | Novel | Radioligand | TSPO
Long-term Cardiac Monitoring in Epilepsy

Conditions:   Focal Epilepsy;   Intractable Epilepsy;   Epileptic Encephalopathy;   Lennox Gastaut Syndrome;   Symptomatic Epilepsy;   Generalized Epilepsy
Intervention:   Device: Reveal LINQ ICM System
Sponsors:   Northwell Health;   Medtronic
Recruiting
ClinicalTrials.gov: Genetic_Disease | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

May 20, 2019Comments OffCardiac | Epilepsy | Longterm | Monitoring
Sickle Cell Disease, Hemechip

Condition:   Sickle Cell Disease
Intervention:   Device: HemeChip
Sponsors:   University Hospitals Cleveland Medical Center;   US federal government;   Amino Kano Teaching Hospital;   Murtala Mohammed Specialist Hospital;   Hasiya Bayero Pediatric Hospital;   University of Nebraska;   University of North Carolina, Chapel Hill;   Case Western Reserve University
Recruiting
ClinicalTrials.gov: Genetic_Disease | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

May 19, 2019Comments OffCell | Disease | Hemechip | Sickle
L-Citrulline Dose Finding Safety Study in MELAS

Condition:   MELAS Syndrome
Intervention:   Drug: L-Citrulline
Sponsors:   Baylor College of Medicine;   National Institutes of Health (NIH);   University of South Florida;   Columbia University
Not yet recruiting
ClinicalTrials.gov: Genetic_Disease | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

May 17, 2019Comments OffDose | Finding | LCitrulline | MELAS | Safety | Study
A Phase 1/2 Study of Intravenous Gene Transfer With an AAV9 Vector Expressing Human Beta-galactosidase in Type II GM1 Gangliosidosis

Conditions:   Lysosomal Diseases;   Gangliosidosis;   GM1
Intervention:   Biological: AAV9-GLB1
Sponsor:   National Human Genome Research Institute (NHGRI)
Recruiting
ClinicalTrials.gov: Genetic_Disease | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

May 16, 2019Comments OffAAV9 | Betagalactosidase | Expressing | Gangliosidosis | Gene | Human | Intravenous | Phase | Study | Transfer | Type | Vector